Arecor Therapeutics PLC
LSE:AREC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Arecor Therapeutics PLC
LSE:AREC
|
UK |
Cash Flow Statement
Cash Flow Statement
Arecor Therapeutics PLC
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(7)
|
(9)
|
(11)
|
(10)
|
(9)
|
(9)
|
(11)
|
(8)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
1
|
1
|
0
|
0
|
1
|
0
|
4
|
3
|
|
| Cash Taxes Paid |
(1)
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
(0)
|
(1)
|
(1)
|
2
|
3
|
(3)
|
(1)
|
|
| Cash from Operating Activities |
(5)
N/A
|
(8)
-48%
|
(11)
-34%
|
(11)
-1%
|
(6)
+46%
|
(6)
+4%
|
(9)
-63%
|
(6)
+33%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
(8)
|
(1)
|
7
|
2
|
2
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-122%
|
(8)
-5 200%
|
(1)
+83%
|
7
N/A
|
2
-74%
|
2
+2%
|
0
-96%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
20
|
0
|
6
|
6
|
0
|
0
|
6
|
6
|
|
| Net Issuance of Debt |
2
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other |
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
|
| Cash from Financing Activities |
21
N/A
|
(0)
N/A
|
5
N/A
|
5
-1%
|
(0)
N/A
|
(0)
+31%
|
6
N/A
|
6
0%
|
|
| Change in Cash | |||||||||
| Effect of Foreign Exchange Rates |
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Change in Cash |
15
N/A
|
(8)
N/A
|
(14)
-61%
|
(7)
+48%
|
0
N/A
|
(4)
N/A
|
(2)
+55%
|
(1)
+64%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(6)
N/A
|
(8)
-49%
|
(11)
-35%
|
(11)
0%
|
(6)
+46%
|
(6)
+4%
|
(9)
-60%
|
(6)
+32%
|
|